Stage III Cervical Cancer Recruiting Phase 2 Trials for Nimotuzumab (DB06192)

Also known as: Cervical cancer stage III / Cervix uteri cancer stage III / Carcinoma uterine cerix stage III / Cervical carcinoma stage III / Carcinoma uterine cervix stage III / Cervix carcinoma stage III / Ca cervix stage III / Carcinoma cervix stage III

IndicationStatusPhase
DBCOND0028824 (Stage III Cervical Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03469531Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerTreatment